Completed NA INTERVENTIONAL 3-arm NCT03708497

Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

The Effect of Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery: a Randomized Controlled Trial

Sponsor: Aswan University Hospital

Conditions Postpartum Hemorrhage

Interventions Tranexamic acid plus misoprostol carbetocin misoprostol

Updated 7 times since 2018 Last updated: Aug 3, 2020 Started: Dec 1, 2018 Primary completion: May 31, 2020 Completion: Jul 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03708497, this NA trial focuses on Postpartum Hemorrhage and remains completed. Sponsored by Aswan University Hospital, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2019 — Sep 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Nov 2018 — Feb 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aswan University Hospital

Data source: Aswan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aswān, Egypt